Adragos Pharma is a globally operating CDMO headquartered in Munich, Germany, specializing in small molecule finished dosage forms. They operate six manufacturing sites across Europe and Japan: Athens (Greece, HPAPI capabilities), Halden (Norway, BFS sterile production), Jura (Switzerland, small-batch clinical/commercial), Kawagoe (Japan, ampoules and tablets), Livron (France, sterile liquids and suppositories), and Leipzig (Germany, semi-solid and non-sterile liquids).
Small molecule drug products, Sterile fill-finish (BFS, ampoules), HPAPI handling, Value-added medicines, Clinical through commercial manufacturing
5 sites worldwide
No reviews available yet.
No documents available.